Furthermore, increased ectopic expression of NLRP6 in RA patient-derived FLS blocks the production of inflammatory cytokines such as IL-1β, IL-6, and TNFα, as well as MMP via inhibition of the NF-κB pathway. The gene discussed is NLRP6; the disease is rheumatoid arthritis.